Skip to Content

Does Cinqair treat all types of asthma?

Medically reviewed by Last updated on Apr 12, 2019.

Official Answer


No, Cinqair is used in more severe asthma with elevated eosinophils (a type of white blood cell) that has not responded well to initial treatments. Cinqair is an anti-interleukin-5 (IL-5) used in adults 18 years and older as an add-on therapy for the maintenance treatment of severe asthma in adults not well-controlled on their current asthma medications.

Cinqair (reslizumab) from Teva Pharmaceuticals, is not for initial asthma treatment, for less severe asthma, or for use as a rescue therapy. 

In studies, patients receiving Cinqair had fewer asthma attacks, a longer time to first attack, and improvement in lung functions tests.

Common side effects with Cinqair include anaphylaxis (a severe, possibly life-threatening allergy), cancer, and muscle pain.

Related Medical Questions

Drug Information

Related Support Groups